nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant radiotherapy in bladder cancer: Time to take a fresh look?
|
Murthy, Vedang |
|
2007 |
25 |
4 |
p. 353-354 2 p. |
artikel |
2 |
A plea for judicious treatment of small renal masses
|
Wolf Jr., J. Stuart |
|
2007 |
25 |
4 |
p. 281-283 3 p. |
artikel |
3 |
Bladder Cancer Think Tank
|
Schoenberg, Mark P. |
|
2007 |
25 |
4 |
p. 329- 1 p. |
artikel |
4 |
Cancer patient advocacy: New opportunities for treatment advances
|
Quale, Diane Zipursky |
|
2007 |
25 |
4 |
p. 351-352 2 p. |
artikel |
5 |
Characterizing vascular parameters in hypoxic regions: A combined magnetic resonance and optical imaging study of a human prostate cancer model
|
Metzger, Gregory |
|
2007 |
25 |
4 |
p. 358-359 2 p. |
artikel |
6 |
Contents
|
|
|
2007 |
25 |
4 |
p. vii-viii nvt p. |
artikel |
7 |
Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI
|
Metzger, Gregory |
|
2007 |
25 |
4 |
p. 357-358 2 p. |
artikel |
8 |
Databases and the future of clinical trials in bladder cancer
|
Adams, R. Mark |
|
2007 |
25 |
4 |
p. 330-332 3 p. |
artikel |
9 |
Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder
|
Das, Kakoli |
|
2007 |
25 |
4 |
p. 317-321 5 p. |
artikel |
10 |
Difficult decisions in urologic oncology: Management of high-grade T1 transitional cell carcinoma of the bladder
|
Soloway, Mark S. |
|
2007 |
25 |
4 |
p. 338-340 3 p. |
artikel |
11 |
Editorial Board
|
|
|
2007 |
25 |
4 |
p. v- 1 p. |
artikel |
12 |
In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models
|
Metzger, Gregory |
|
2007 |
25 |
4 |
p. 358- 1 p. |
artikel |
13 |
KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties
|
Metzger, Gregory |
|
2007 |
25 |
4 |
p. 359-360 2 p. |
artikel |
14 |
Long-term outcome of radiation-based conservation therapy for invasive bladder cancer
|
Chung, Peter W.M. |
|
2007 |
25 |
4 |
p. 303-309 7 p. |
artikel |
15 |
Markers of detection
|
Messing, Edward |
|
2007 |
25 |
4 |
p. 344-347 4 p. |
artikel |
16 |
Masthead
|
|
|
2007 |
25 |
4 |
p. iv- 1 p. |
artikel |
17 |
No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
|
Kwak, Cheol |
|
2007 |
25 |
4 |
p. 310-316 7 p. |
artikel |
18 |
Penile keratoacanthoma associated with urothelial carcinoma of the bladder in Muir-Torre syndrome
|
Cimen, Sertac |
|
2007 |
25 |
4 |
p. 326-328 3 p. |
artikel |
19 |
Phase II trial of thalidomide and daily oral dexamethasone for treatment of hormone refractory prostate cancer progressing after chemotherapy
|
Romero, Silvia |
|
2007 |
25 |
4 |
p. 284-290 7 p. |
artikel |
20 |
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
|
Ritter, Mark A. |
|
2007 |
25 |
4 |
p. 356-357 2 p. |
artikel |
21 |
Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts
|
Malaeb, Bahaa S. |
|
2007 |
25 |
4 |
p. 291-297 7 p. |
artikel |
22 |
Searching for novel therapeutics and targets: Insights from clinical trials
|
Mitra, Anirban P. |
|
2007 |
25 |
4 |
p. 341-343 3 p. |
artikel |
23 |
Survey Section Editorial Board
|
|
|
2007 |
25 |
4 |
p. 355- 1 p. |
artikel |
24 |
Talking to patients about risk
|
Deibel, Terry L. |
|
2007 |
25 |
4 |
p. 348-350 3 p. |
artikel |
25 |
Testicular granulosa cell tumor of adult type: A new case and a review of the literature
|
Ditonno, Pasquale |
|
2007 |
25 |
4 |
p. 322-325 4 p. |
artikel |
26 |
The use and abuse of data: Nomograms and talking to patients about clinical medicine
|
Lerner, Seth P. |
|
2007 |
25 |
4 |
p. 333-337 5 p. |
artikel |
27 |
Trends in renal cancer surgery and patient provider characteristics associated with partial nephrectomy in the United States
|
Porter, Michael P. |
|
2007 |
25 |
4 |
p. 298-302 5 p. |
artikel |